Go to
JCI Insight
Citations to this article
Jorge Filmus, Scott B. Selleck
Published August 15, 2001
Citation Information: J Clin Invest. 2001;108(4):497-501. https://doi.org/10.1172/JCI13712.
Citation Information: J Clin Invest. 2001;108(4):497-501. https://doi.org/10.1172/JCI13712.
Total citations by year
Citation information
Citations to this article (156)
| Title and authors | Publication | Year |
|---|---|---|
|
Epigenetic Mechanisms Histone Deacetylase–Dependent Regulate the Glioblastoma Angiogenic Matrisome and Disrupt Endothelial Cell Behavior In Vitro
Menezes A, Julião G, Mariath F, Ferreira AL, Oliveira-Nunes MC, Gallucci L, Evaristo JA, Nogueira FC, Pereira DD, Carneiro K |
Molecular & cellular proteomics : MCP | 2024 |
|
Glypican-1-targeted antibody–drug conjugate inhibits the growth of glypican-1-positive glioblastoma
Uchida S, Serada S, Suzuki Y, Funajima E, Kitakami K, Dobashi K, Tamatani S, Sato Y, Beppu T, Ogasawara K, Naka T |
Neoplasia (New York, N.Y.) | 2024 |
|
Glypican-4 serum levels are associated with cognitive dysfunction and vascular risk factors in Parkinson’s disease
Tatenhorst L, Maass F, Paul H, Dambeck V, Bähr M, Dono R, Lingor P |
Scientific Reports | 2024 |
|
Hedgehog on the Move: Glypican-Regulated Transport and Gradient Formation in Drosophila.
Jiménez-Jiménez C, Grobe K, Guerrero I |
Cells | 2024 |
|
Pan-cancer analysis and the oncogenic role of Glypican 1 in hepatocellular carcinoma
Cao L, Li F, Cai S, Zhang J, Guo C, Ali S, Zhou J, Jing X, Wang X, Qin Y, Wu F |
Scientific Reports | 2024 |
|
Excess Dally-like Induces Malformation of Drosophila Legs
Zhang X, Wang Y, Zhao W, Yang S, Moussian B, Zhao Z, Zhang J, Dong W |
Cells | 2024 |
|
An Early Gestation Plasma Inflammasome in Rural Bangladeshi Women
Kim H, Bedsaul-Fryer JR, Schulze KJ, Sincerbeaux G, Baker S, Rebholz CM, Wu LS, Gogain J, Cuddeback L, Yager JD, De Luca LM, Siddiqua TJ, West KP Jr |
Biomolecules | 2024 |
|
Plasma proteins associated with plant-based diets: Results from the Atherosclerosis Risk in Communities (ARIC) study and Framingham Heart Study (FHS).
Kim H, Chen J, Prescott B, Walker ME, Grams ME, Yu B, Vasan RS, Floyd JS, Sotoodehnia N, Smith NL, Arking DE, Coresh J, Rebholz CM |
Clinical nutrition (Edinburgh, Scotland) | 2024 |
|
GPC3-mediated metabolic rewiring of diabetic mesenchymal stromal cells enhances their cardioprotective functions via PKM2 activation
Joladarashi D, Thej C, Mallaredy V, Magadum A, Cimini M, Gonzalez C, Truongcao M, Nigro JT, Sethi MK, Gibb AA, Benedict C, Koch WJ, Kishore R |
iScience | 2024 |
|
Exploring the Role of Peroxisome Proliferator-Activated Receptors and Endothelial Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease
Madariaga Traconis AP, Uribe-Esquivel M, Barbero Becerra VJ |
Cells | 2024 |
|
The anti-glypican 1 AT101 antibody as targeting agent to effectively deliver chitosan nanobubbles to glioblastoma cells
Di Cintio F, Argenziano M, Scomparin A, Capolla S, Busato D, Steffè A, Mangogna A, Sblattero D, Cavalli R, Macor P, Dal Bo M, Toffoli G |
Nanomedicine | 2024 |
|
Integrated imaging probe and bispecific antibody development enables in vivo targeting of glypican-3–expressing hepatocellular carcinoma
Habibollahi P, Gurevich A, Hui JZ, Weinfurtner K, McClung G, Adler J, Soulen MC, Kaplan DE, Nadolski GJ, Hunt SJ, Tsourkas A, Gade TP |
Molecular cancer therapeutics | 2024 |
|
Development of a basement membrane gene signature and identification of the potential candidate therapeutic targets for pancreatic cancer
Lin K, Xu D, Wang X, Shi J, Gao W |
Gland Surgery | 2023 |
|
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies
Daei Sorkhabi A, Mohamed Khosroshahi L, Sarkesh A, Mardi A, Aghebati-Maleki A, Aghebati-Maleki L, Baradaran B |
Frontiers in immunology | 2023 |
|
The Glycosaminoglycan Side Chains and Modular Core Proteins of Heparan Sulphate Proteoglycans and the Varied Ways They Provide Tissue Protection by Regulating Physiological Processes and Cellular Behaviour
Farrugia BL, Melrose J |
International journal of molecular sciences | 2023 |
|
Global impact of proteoglycan science on human diseases
Xie C, Schaefer L, Iozzo RV |
iScience | 2023 |
|
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma.
Busato D, Capolla S, Durigutto P, Mossenta M, Bozzer S, Sblattero D, Macor P, Dal Bo M, Toffoli G |
Journal of Translational Medicine | 2023 |
|
GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer
G Chen, D Luo, N Zhong, D Li, J Zheng, H Liao, Z Li, X Lin, Q Chen, C Zhang, Y Lu, Y Chan, Q Ren, N Wang, Y Feng |
Frontiers in immunology | 2022 |
|
Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma
X Zheng, X Liu, Y Lei, G Wang, M Liu |
Frontiers in Oncology | 2022 |
|
A natural genetic variation screen identifies insulin signaling, neuronal communication, and innate immunity as modifiers of hyperglycemia in the absence of Sirt1
Palu RA, Owings KG, Garces JG, Nicol A |
G3: Genes|Genomes|Genetics | 2022 |
|
Matrix proteoglycans in tumor inflammation and immunity.
Deb G, Cicala A, Papadas A, Asimakopoulos F |
American journal of physiology. Cell physiology | 2022 |
|
Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies
Mossenta M, Busato D, Dal Bo M, Macor P, Toffoli G |
International journal of molecular sciences | 2022 |
|
PFKP and GPC6 Variants Were Correlated with Alcohol-Induced Femoral Head Necrosis Risk in the Chinese Han Population
Liu C, Liu X, Li X |
Pharmacogenomics and Personalized Medicine | 2022 |
|
GPC1 Is Associated with Poor Prognosis and Treg Infiltration in Colon Adenocarcinoma
Liu Y, Ren H, Yang MQ, Li JY |
Computational and mathematical methods in medicine | 2022 |
|
The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma
Busato D, Mossenta M, Dal Bo M, Macor P, Toffoli G |
International journal of molecular sciences | 2022 |
|
Advances in CAR-T cell therapy for malignant solid tumors.
Liu J, Tu X, Liu L, Fang W |
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences | 2022 |
|
Gone with the Wnt(less): a mechanistic perspective on the journey of Wnt
Mani N, Nygaard R, Mancia F |
Biochemical Society transactions | 2022 |
|
AI-Based Radiological Imaging for HCC: Current Status and Future of Ultrasound
H Maruyama, T Yamaguchi, H Nagamatsu, S Shiina |
Diagnostics | 2021 |
|
Overexpression of Annexin A2 promotes proliferation by forming a Glypican 1/c-Myc positive feedback loop: prognostic significance in human glioma
X Li, S Nie, Z Lv, L Ma, Y Song, Z Hu, X Hu, Z Liu, G Zhou, Z Dai, T Song, J Liu, S Wang |
Cell Death and Disease | 2021 |
|
A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma
E Munekage, S Serada, S Tsujii, K Yokota, K Kiuchi, K Tominaga, M Fujimoto, M Kanda, S Uemura, T Namikawa, T Nomura, I Murakami, K Hanazaki, T Naka |
Neoplasia (New York, N.Y.) | 2021 |
|
Inhibition of glypican-1 expression induces an activated fibroblast phenotype in a human bone marrow-derived stromal cell-line
SP Kaur, A Verma, HK Lee, LM Barnett, PR Somanath, BS Cummings |
Scientific Reports | 2021 |
|
Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy
SL Huang, YM Wang, QY Wang, GG Feng, FQ Wu, LM Yang, , HW Xin |
Frontiers in Genetics | 2021 |
|
Involvement of Kynurenine Pathway in Hepatocellular Carcinoma
S Krishnamurthy, D Gilot, SB Ahn, V Lam, JS Shin, GJ Guillemin, B Heng |
Cancers | 2021 |
|
Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3
N Li, MR Spetz, D Li, M Ho |
Pharmacology & Therapeutics | 2021 |
|
The prognostic value of arginase-1 and glypican-3 expression levels in patients after surgical intrahepatic cholangiocarcinoma resection
Z Qiang, H Zhang, S Jin, C Yan, Z Li, L Tao, H Yu |
World journal of surgical oncology | 2021 |
|
Glypican-1 Overexpression in Different Types of Breast Cancers
FO Alshammari, YM Al-Saraireh, AM Youssef, YM AL-sarayra, HM Alrawashdeh |
OncoTargets and therapy | 2021 |
|
Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells
P Meng, YF Zhang, W Zhang, X Chen, T Xu, S Hu, X Liang, M Feng, X Yang, M Ho |
Scientific Reports | 2021 |
|
A Novel Prognostic and Predictive Signature for Lung Adenocarcinoma Derived from Combined Hypoxia and Infiltrating Immune Cell-Related Genes in TCGA Patients
X Wu, J Zhu, W Liu, M Jin, M Xiong, K Hu |
International journal of general medicine | 2021 |
|
Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment.
Bakrania A, Zheng G, Bhat M |
Pharmaceutics | 2021 |
|
Multi-Modal Imaging Probe for Glypican-3 Overexpressed in Orthotopic Hepatocellular Carcinoma.
Feng S, Meng X, Li Z, Chang TS, Wu X, Zhou J, Joshi B, Choi EY, Zhao L, Zhu J, Wang TD |
Journal of Medicinal Chemistry | 2021 |
|
Heparan Sulfate Proteoglycans: Key Mediators of Stem Cell Function
M Ravikumar, RA Smith, V Nurcombe, SM Cool |
Frontiers in Cell and Developmental Biology | 2020 |
|
Anti-glypican-1 antibody–drug conjugate is a potential therapy against pancreatic cancer
T Nishigaki, T Takahashi, S Serada, M Fujimoto, T Ohkawara, H Hara, T Sugase, T Otsuru, Y Saito, S Tsujii, T Nomura, K Tanaka, Y Miyazaki, T Makino, Y Kurokawa, K Nakajima, H Eguchi, M Yamasaki, M Mori, Y Doki, T Naka |
British Journal of Cancer | 2020 |
|
Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside
G Siracusano, M Tagliamonte, L Buonaguro, L Lopalco |
Human vaccines | 2020 |
|
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
M Mossenta, D Busato, MD Bo, G Toffoli |
Cancers | 2020 |
|
Engineering of HN3 increases the tumor targeting specificity of exosomes and upgrade the anti-tumor effect of sorafenib on HuH-7 cells
C He, DJ Ali, Y Li, Y Zhu, B Sun, Z Xiao |
PeerJ | 2020 |
|
Cleavage of proteoglycans, plasma proteins and the platelet-derived growth factor receptor in the hemorrhagic process induced by snake venom metalloproteinases
AF Asega, MC Menezes, D Trevisan-Silva, D Cajado-Carvalho, L Bertholim, AK Oliveira, A Zelanis, SM Serrano |
Scientific Reports | 2020 |
|
Synthesis, Molecular Docking Screening and Anti-Proliferative Potency Evaluation of Some New Imidazo[2,1-b]Thiazole Linked Thiadiazole Conjugates
HR Rashdan, AH Abdelmonsef, IA Shehadi, SM Gomha, AM Soliman, HK Mahmoud |
Molecules (Basel, Switzerland) | 2020 |
|
Glypican-3: A molecular marker for the detection and treatment of hepatocellular carcinoma
TC Shih, L Wang, HC Wang, YJ Wan |
Liver Research | 2020 |
|
Assembling custom side chains on proteoglycans to interrogate their function in living cells
W Wang, N Han, Y Xu, Y Zhao, L Shi, J Filmus, F Li |
Nature Communications | 2020 |
|
The Role of BAR Proteins and the Glycocalyx in Brain Endothelium Transcytosis
DM Leite, D Matias, G Battaglia |
Cells | 2020 |
|
Glypican-3: A New Target for Diagnosis and Treatment of Hepatocellular Carcinoma
M Guo, H Zhang, J Zheng, Y Liu |
Journal of Cancer | 2020 |
|
Glypican-3 Expression in Patients with Oral Squamous Cell Carcinoma
Azadeh Andisheh-Tadbir, Amir Saeed Goharian, Mohammad Ali Ranjbar |
Journal of Dentistry | 2020 |
|
Extracellular Matrix: Surface Proteoglycans
Park PW |
Reference Module in Biomedical Sciences | 2020 |
|
Anti-proliferative and anti-apoptotic potential effects of epigallocatechin-3-gallate and/or metformin on hepatocellular carcinoma cells: in vitro study
D Sabry, OO Abdelaleem, AM Ali, RA Mohammed, ND Abdel-Hameed, A Hassouna, WA Khalifa |
Molecular Biology Reports | 2019 |
|
Clinical Impact of Circulated miR-1291 in Plasma of Patients with Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC): Implication on Glypican-3 Expression
NA Hagag, YB Ali, AA Elsharawy, RM Talaat |
Journal of Gastrointestinal Cancer | 2019 |
|
Plasma and Joint Fluid Glypican-3 Are Inversely Correlated with the Severity of Knee Osteoarthritis
W Udomsinprasert, E McConachie, S Ngarmukos, N Theerawattanapong, A Tanavalee, S Honsawek |
Cartilage | 2019 |
|
Next-Generation Cancer Immunotherapy Targeting Glypican-3
Y Shimizu, T Suzuki, T Yoshikawa, I Endo, T Nakatsura |
Frontiers in Oncology | 2019 |
|
The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer
S Wang, Y Qiu, B Bai |
Frontiers in Oncology | 2019 |
|
The Role of Glypican-3 in Regulating Wnt, YAP, and Hedgehog in Liver Cancer
A Kolluri, M Ho |
Frontiers in Oncology | 2019 |
|
Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
CW Lee, HI Tsai, WC Lee, SW Huang, CY Lin, YC Hsieh, T Kuo, CW Chen, MC Yu |
Journal of Clinical Medicine | 2019 |
|
Simpson−Golabi−Behmel syndrome type 1 with subclinical hypothyroidism: A case report
J Zhang, K Mu, H Xu, Y Guo, Z Liu, L Wang, J Li, F Zhang, Y Kou, X Yuan |
Medicine | 2019 |
|
The Non-Fibrillar Side of Fibrosis: Contribution of the Basement Membrane, Proteoglycans, and Glycoproteins to Myocardial Fibrosis
M Chute, P Aujla, S Jana, Z Kassiri |
Journal of Cardiovascular Development and Disease | 2019 |
|
Functionalized Upconversion Nanoparticles for Targeted Labelling of Bladder Cancer Cells
D Polikarpov, L Liang, A Care, A Sunna, D Campbell, B Walsh, I Balalaeva, A Zvyagin, D Gillatt, E Guryev |
Biomolecules | 2019 |
|
Plasma and tumoral glypican‐3 levels are correlated in patients with hepatitis C virus‐related hepatocellular carcinoma
Y Shimizu, S Mizuno, N Fujinami, T Suzuki, K Saito, M Konishi, S Takahashi, N Gotohda, T Tada, H Toyoda, T Kumada, M Miura, K Suto, T Yamaji, T Matsuda, I Endo, T Nakatsura |
Cancer Science | 2019 |
|
The expansion of targetable biomarkers for CAR T cell therapy
MH Townsend, G Shrestha, RA Robison, KL ONeill |
Journal of Experimental & Clinical Cancer Research | 2018 |
|
Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis
J Zhang, M Zhang, H Ma, X Song, L He, X Ye, X Li |
Medicine | 2018 |
|
Evaluation of the expression of Glypican-3 in benign and malignant salivary gland tumors
A Andisheh-Tadbir, MJ Ashraf, A Gudarzi, R Zare |
Journal of Oral Biology and Craniofacial Research | 2018 |
|
Elevated GPC3 level promotes cell proliferation in liver cancer
S Wang, N Chen, Y Chen, L Sun, L Li, H Liu |
Oncology Letters | 2018 |
|
Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas
Sherif El-Saadany, Taher El-Demerdash, Amal Helmy, Wael Wahid Mayah, Boshra El-Sayed Hussein, Mohammed Hassanien, Nehal Elmashad, Mahmoud Ali Fouad, Eman Ahmed Basha |
Asian Pacific Journal of Cancer Prevention | 2018 |
|
I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma
JA Carrasquillo, JA ODonoghue, V Beylergil, S Ruan, N Pandit-Taskar, SM Larson, PM Smith-Jones, SK Lyashchenko, N Ohishi, T Ohtomo, GK Abou-Alfa |
EJNMMI Research | 2018 |
|
Phosphorothioate-Modified AP613-1 Specifically Targets GPC3 when Used for Hepatocellular Carcinoma Cell Imaging
L Dong, H Zhou, M Zhao, X Gao, Y Liu, D Liu, W Guo, H Hu, Q Xie, J Fan, J Lin, W Wu |
Molecular Therapy — Nucleic Acids | 2018 |
|
High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma
C Zhou, Y Dong, X Sun, X Sui, H Zhu, Y Zhao, Y Zhang, C Mason, Q Zhu, S Han |
Cancer Medicine | 2018 |
|
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
Y Wang, J Liu, H Pan, J Xing, X Wu, Q Li, Z Wang |
Journal of visualized experiments : JoVE | 2018 |
|
Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers
E Hull, MK Montgomery, K Leyva |
International journal of molecular sciences | 2017 |
|
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
GK Abou-Alfa, CJ Yen, CH Hsu, J ODonoghue, V Beylergil, S Ruan, N Pandit-Taskar, B Gansukh, SK Lyashchenko, J Ma, P Wan, YY Shao, ZZ Lin, C Frenette, B ONeil, L Schwartz, PM Smith-Jones, T Ohtomo, T Tanaka, H Morikawa, Y Maki, N Ohishi, YC Chen, T Agajanov, F Boisserie, LD Laurenzio, R Lee, SM Larson, AL Cheng, JA Carrasquilo |
Cancer Chemotherapy and Pharmacology | 2017 |
|
Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma
H Lu, F Niu, F Liu, J Gao, Y Sun, X Zhao |
Cancer Medicine | 2017 |
|
Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma
E Harada, S Serada, M Fujimoto, Y Takahashi, T Takahashi, H Hara, R Nakatsuka, T Sugase, T Nishigaki, Y Saito, K Hiramatsu, S Nojima, R Mitsuo, T Ohkawara, E Morii, M Mori, Y Doki, Y Kaneda, T Naka |
Oncotarget | 2017 |
|
Characterization of a new monoclonal anti-glypican-3 antibody specific to the hepatocellular carcinoma cell line, HepG2
P Vongchan, RJ Linhardt |
World journal of hepatology | 2017 |
|
Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10
W Cheng, PC Huang, HM Chao, YM Jeng, HC Hsu, HW Pan, WL Hwu, YM Lee |
Oncotarget | 2017 |
|
Extracellular Matrix, a Hard Player in Angiogenesis
M Mongiat, E Andreuzzi, G Tarticchio, A Paulitti |
International journal of molecular sciences | 2016 |
|
Targeted nanobubbles in low-frequency ultrasound-mediated gene transfection and growth inhibition of hepatocellular carcinoma cells
B Wu, Q Qiao, X Han, H Jing, H Zhang, H Liang, W Cheng |
Tumor Biology | 2016 |
|
Aptamers against Cells Overexpressing Glypican 3 from Expanded Genetic Systems Combined with Cell Engineering and Laboratory Evolution
L Zhang, Z Yang, TL Trinh, IT Teng, S Wang, KM Bradley, S Hoshika, Q Wu, S Cansiz, DJ Rowold, C McLendon, MS Kim, Y Wu, C Cui, Y Liu, W Hou, K Stewart, S Wan, C Liu, SA Benner, W Tan |
Angewandte Chemie (International ed. in English) | 2016 |
|
Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization
Q Truong, IO Justiniano, AL Nocon, JT Soon, S Wissmueller, DH Campbell, BJ Walsh |
Journal of Cancer | 2016 |
|
Sensitivity and Specificity of Galectin-3 and Glypican-3 in Follicular-Patterned and Other Thyroid Neoplasms
DR Al-sharaky |
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH | 2016 |
|
THE GLYCOCALYX AND TRAUMA: A REVIEW
AZ Chignalia, F Yetimakman, SC Christiaans, S Unal, B Bayrakci, BM Wagener, RT Russell, JD Kerby, JF Pittet, RO Dull |
Shock | 2016 |
|
Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity
W Li, L Guo, P Rathi, E Marinova, X Gao, MF Wu, H Liu, G Dotti, S Gottschalk, LS Metelitsa, A Heczey |
Human Gene Therapy | 2016 |
|
The Heparan Sulfate Proteoglycan Glypican-6 Is Upregulated in the Failing Heart, and Regulates Cardiomyocyte Growth through ERK1/2 Signaling
AO Melleby, ME Strand, A Romaine, KM Herum, B Skrbic, CP Dahl, I Sjaastad, AE Fiane, J Filmus, G Christensen, IG Lunde, NK Karamanos |
PloS one | 2016 |
|
An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma Cells
K Ly, R Essalmani, R Desjardins, NG Seidah, R Day |
The Journal of biological chemistry | 2016 |
|
Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
M Li, W Zhang, B Wang, Y Gao, Z Song, QC Zheng |
International Journal of Nanomedicine | 2016 |
|
Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer
S Han, X Ma, Y Zhao, H Zhao, A Batista, S Zhou, X Zhou, Y Yang, T Wang, J Bi, Z Xia, Z Bai, I Garkavtsev, Z Zhang |
Oncotarget | 2016 |
|
Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma
K Ofuji, K Saito, S Suzuki, M Shimomura, H Shirakawa, D Nobuoka, Y Sawada, M Yoshimura, N Tsuchiya, M Takahashi, T Yoshikawa, Y Tada, M Konishi, S Takahashi, N Gotohda, Y Nakamoto, T Nakatsura |
Oncotarget | 2016 |
|
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
AO Kaseb, M Hassan, S Lacin, R Abdel-Wahab, HM Amin, A Shalaby, RA Wolff, J Yao, A Rashid, B Vennapusa, J Feng, T Ohtomo |
Oncotarget | 2016 |
|
PTPσ functions as a presynaptic receptor for the glypican-4/LRRTM4 complex and is essential for excitatory synaptic transmission
JS Ko, G Pramanik, JW Um, JS Shim, D Lee, KH Kim, GY Chung, G Condomitti, HM Kim, H Kim, J Wit, KS Park, K Tabuchi, J Ko |
Proceedings of the National Academy of Sciences | 2015 |
|
Proteoglycans in Normal and Healing Skin
MM Smith, J Melrose |
Advances in Skin & Wound Care | 2015 |
|
Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors
A Farnedi, S Rossi, N Bertani, M Gulli, EM Silini, MT Mucignat, T Poli, E Sesenna, D Lanfranco, L Montebugnoli, E Leonardi, C Marchetti, R Cocchi, A Ambrosini-Spaltro, MP Foschini, R Perris |
BMC Cancer | 2015 |
|
Expression of Glypican 3 in low and high grade urothelial carcinomas
O Aydin, L Yildiz, S Baris, C Dundar, F Karagoz |
Diagnostic Pathology | 2015 |
|
Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells
Y Liu, D Zheng, M Liu, J Bai, X Zhou, B Gong, J Lü, Y Zhang, H Huang, W Luo, G Huang |
Tumor Biology | 2015 |
|
Diagnostic and prognostic significance of glypican�5 and glypican�6 gene expression levels in gastric adenocarcinoma
M Dinccelik‑Aslan, G Gumus‑Akay, A Elhan, E Unal, A Tukun |
Molecular and Clinical Oncology | 2015 |
|
Immunological landscape and immunotherapy of hepatocellular carcinoma
J Prieto, I Melero, B Sangro |
Nature Reviews Gastroenterology & Hepatology | 2015 |
|
Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk: EMT Gene Variants and Ovarian Cancer Risk
EK Amankwah, HY Lin, JP Tyrer, K Lawrenson, J Dennis, G Chornokur, KK Aben, H Anton-Culver, N Antonenkova, F Bruinsma, EV Bandera, YT Bean, MW Beckmann, M Bisogna, L Bjorge, N Bogdanova, LA Brinton, A Brooks-Wilson, CH Bunker, R Butzow, IG Campbell, K Carty, Z Chen, YA Chen, J Chang-Claude, LS Cook, DW Cramer, JM Cunningham, C Cybulski, A Dansonka-Mieszkowska, A Bois, E Despierre, E Dicks, JA Doherty, T Dörk, M Dürst, DF Easton, DM Eccles, RP Edwards, AB Ekici, PA Fasching, BL Fridley, YT Gao, A Gentry-Maharaj, GG Giles, R Glasspool, MT Goodman, J Gronwald, P Harrington, P Harter, HN Hasmad, A Hein, F Heitz, MA Hildebrandt, P Hillemanns, CK Hogdall, E Hogdall, S Hosono, ES Iversen, A Jakubowska, A Jensen, BT Ji, BY Karlan, H Jim, M Kellar, LA Kiemeney, C Krakstad, SK Kjaer, J Kupryjanczyk, D Lambrechts, S Lambrechts, ND Le, AW Lee, S Lele, A Leminen, J Lester, DA Levine, D Liang, BK Lim, J Lissowska, K Lu, J Lubinski, L Lundvall, LF Massuger, K Matsuo, V McGuire, JR McLaughlin, I McNeish, U Menon, RL Milne, F Modugno, KB Moysich, RB Ness, H Nevanlinna, U Eilber, K Odunsi, SH Olson, I Orlow, S Orsulic, RP Weber, J Paul, CL Pearce, T Pejovic, LM Pelttari, J Permuth-Wey, MC Pike, EM Poole, HA Risch, B Rosen, MA Rossing, JH Rothstein, A Rudolph, IB Runnebaum, IK Rzepecka, HB Salvesen, E Schernhammer, I Schwaab, XO Shu, YB Shvetsov, N Siddiqui, W Sieh, H Song, MC Southey, B Spiewankiewicz, L Sucheston-Campbell, SH Teo, KL Terry, PJ Thompson, L Thomsen, IL Tangen, SS Tworoger, AM van Altena, RA Vierkant, I Vergote, CS Walsh, S Wang-Gohrke, N Wentzensen, AS Whittemore, KG Wicklund, LR Wilkens, AH Wu, X Wu, YL Woo, H Yang, W Zheng, A Ziogas, LE Kelemen, A Berchuck, JM Schildkraut, SJ Ramus, EL Goode, AN Monteiro, SA Gayther, SA Narod, PD Pharoah, TA Sellers, CM Phelan |
Genetic Epidemiology | 2015 |
|
Systems genetic analysis of hippocampal neuroanatomy and spatial learning in mice: Systems genetic analysis of hippocampal neuroanatomy and spatial learning
A Delprato, B Bonheur, MP Algéo, P Rosay, L Lu, RW Williams, WE Crusio |
Genes Brain & Behavior | 2015 |
|
Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis
WK Xiao, CY Qi, D Chen, SQ Li, SJ Fu, BG Peng, LJ Liang |
BMC Cancer | 2014 |
|
Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma
HJ Lee, JE Yeon, SJ Suh, SJ Lee, EL Yoon, K Kang, YJ Yoo, JH Kim, YS Seo, HJ Yim, KS Byun |
Gut and Liver | 2014 |
|
Dysplastic nodules with glypican-3 positive immunostaining: a risk for early hepatocellular carcinoma
L Gong, LX Wei, P Ren, WD Zhang, XY Liu, XJ Han, L Yao, SJ Zhu, M Lan, YH Li, W Zhang |
PloS one | 2014 |
|
Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: A meta-analysis
J Li, JZ Gao, JL Du, LX Wei |
World journal of gastroenterology : WJG | 2014 |
|
Bioinformatic and immunological analysis reveals lack of support for measles virus related mimicry in Crohn’s disease
D Polymeros, ZP Tsiamoulos, AL Koutsoumpas, DS Smyk, MG Mytilinaiou, K Triantafyllou, DP Bogdanos, SD Ladas |
BMC Medicine | 2014 |
|
Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma
JG Sham, FM Kievit, JR Grierson, RS Miyaoka, MM Yeh, M Zhang, RS Yeung, S Minoshima, JO Park |
Journal of Nuclear Medicine | 2014 |
|
Glypican-3 antibodies: A new therapeutic target for liver cancer
M Feng, M Ho |
FEBS Letters | 2014 |
|
Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma
M Ikeda, S Ohkawa, T Okusaka, S Mitsunaga, S Kobayashi, C Morizane, I Suzuki, S Yamamoto, J Furuse |
Cancer Science | 2014 |
|
Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma
T Nakatsura, K Ofuji, K Saito, T Yoshikawa |
Journal of Hepatocellular Carcinoma | 2014 |
|
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
M Feng, W Gao, R Wang, W Chen, YG Man, WD Figg, XW Wang, DS Dimitrov, M Ho |
Proceedings of the National Academy of Sciences | 2013 |
|
Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients
B Li, H Liu, HW Shang, P Li, N Li, HG Ding |
African health sciences | 2013 |
|
Identification and expression analysis of zebrafish glypicans during embryonic development
M Gupta, M Brand |
PloS one | 2013 |
|
Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican‑3‑derived peptide
Y Tada, T Yoshikawa, M Shimomura, Y Sawada, M Sakai, H Shirakawa, D Nobuoka, T Nakatsura |
International journal of oncology | 2013 |
|
Regulation of TGFβ superfamily signaling by two separable domains of glypican LON-2 in C. elegans
S Taneja-Bageshwar, TL Gumienny |
Worm | 2013 |
|
A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis
C Xu, Z Yan, L Zhou, Y Wang |
Journal of Cancer Research and Clinical Oncology | 2013 |
|
The Glomerular Basement Membrane as a Model System to Study the Bioactivity of Heparan Sulfate Glycosaminoglycans
KJ McCarthy, DJ Wassenhove-McCarthy |
Microscopy and Microanalysis | 2012 |
|
Two functional domains in C. elegans glypican LON-2 can independently inhibit BMP-like signaling
S Taneja-Bageshwar, TL Gumienny |
Developmental Biology | 2012 |
|
An overview of biomarkers for the diagnosis of hepatocellular carcinoma.
Abu El Makarem M |
Hepatitis Monthly | 2012 |
|
Heparan sulphate, its derivatives and analogues share structural characteristics that can be exploited, particularly in inhibiting microbial attachment.
Rudd TR, Hughes A, Holman J, Solari V, Ferreira Ede O, Domingues RM, Yates EA |
2012 | |
|
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
RV Iozzo, RD Sanderson |
Journal of Cellular and Molecular Medicine | 2011 |
|
Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling
F Li, W Shi, M Capurro, J Filmus |
The Journal of Cell Biology | 2011 |
|
Hepatocellular tumors: immunohistochemical analyses for classification and prognostication
RC Lo, IO Ng |
Chinese Journal of Cancer Research | 2011 |
|
Glypican-1 stimulates Skp2 autoinduction loop and G1/S transition in endothelial cells
D Qiao, K Meyer, A Friedl |
The Journal of biological chemistry | 2011 |
|
Hepatocyte proliferation and hepatomegaly induced by phenobarbital and 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene is suppressed in hepatocyte-targeted glypican 3 transgenic mice
CW Lin, WM Mars, S Paranjpe, S Donthamsetty, VS Bhave, LI Kang, A Orr, WC Bowen, AW Bell, GK Michalopoulos |
Hepatology | 2011 |
|
Chemiluminescence enzyme immunoassay based on magnetic nanoparticles for detection of hepatocellular carcinoma marker glypican-3
QY Zhang, H Chen, Z Lin, JM Lin |
Journal of Pharmaceutical Analysis | 2011 |
|
Array comparative genomic hybridization analysis in patients with anophthalmia, microphthalmia, and coloboma
G Raca, CA Jackson, L Kucinskas, B Warman, JT Shieh, A Schneider, TM Bardakjian, LA Schimmenti |
Genetics in Medicine | 2011 |
|
Diagnostic and prognostic role of serum glypican 3 in patients with hepatocellular carcinoma
H Özkan, H Erdal, E Koçak, H Tutkak, Z Karaeren, M Yakut, S Köklü |
Journal of Clinical Laboratory Analysis | 2011 |
|
Proteoglycans in host–pathogen interactions: molecular mechanisms and therapeutic implications
AH Bartlett, PW Park |
Expert Reviews in Molecular Medicine | 2010 |
|
Expression of glypican 3 in placental site trophoblastic tumor
RJ Ou-Yang, P Hui, XJ Yang, DL Zynger |
Diagnostic Pathology | 2010 |
|
Involvement of aberrant glycosylation in thyroid cancer
E Miyoshi, Y Ito, Y Miyoshi |
Journal of Oncology | 2010 |
|
Present and future possibilities for early diagnosis of hepatocellular carcinoma
P Stefaniuk, J Cianciara, A Wiercinska-Drapalo |
World journal of gastroenterology : WJG | 2010 |
|
Gene silencing of glypican-3 in clear cell carcinoma of the ovary renders it more sensitive to the apoptotic agent paclitaxel in vitro and in vivo
T Umezu, K Shibata, M Shimaoka, H Kajiyama, E Yamamoto, K Ino, A Nawa, T Senga, F Kikkawa |
Cancer Science | 2010 |
|
A Novel Mechanism of Sequestering Fibroblast Growth Factor 2 by Glypican in Lipid Rafts, Allowing Skeletal Muscle Differentiation
J Gutiérrez, E Brandan |
Molecular and cellular biology | 2010 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
|
Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis
YH Jen, M Musacchio, AD Lander |
Neural development | 2009 |
|
Mutations in the Heparan-Sulfate Proteoglycan Glypican 6 (GPC6) Impair Endochondral Ossification and Cause Recessive Omodysplasia
AB Campos-Xavier, D Martinet, J Bateman, D Belluoccio, L Rowley, TY Tan, A Baxová, KH Gustavson, ZU Borochowitz, AM Innes, S Unger, JS Beckmann, L Mittaz, D Ballhausen, A Superti-Furga, R Savarirayan, L Bonafé |
The American Journal of Human Genetics | 2009 |
|
Craniofacial skeletal defects of adult zebrafish Glypican 4 (knypek) mutants
EE LeClair, SR Mui, A Huang, JM Topczewska, J Topczewski |
Developmental Dynamics | 2009 |
|
Glypicans
J Filmus, M Capurro, J Rast |
Genome biology | 2008 |
|
Extracellular matrix in the trabecular meshwork
TS Acott, MJ Kelley |
Experimental Eye Research | 2008 |
|
Glypican-1 Regulates Anaphase Promoting Complex/Cyclosome Substrates and Cell Cycle Progression in Endothelial Cells
D Qiao, X Yang, K Meyer, A Friedl, R Assoian |
Molecular biology of the cell | 2008 |
|
A phenotypic comparison of intervertebral disc and articular cartilage cells in the rat
CR Lee, D Sakai, T Nakai, K Toyama, J Mochida, M Alini, S Grad |
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society | 2007 |
|
Glycomics of proteoglycan biosynthesis in murine embryonic stem cell differentiation
AV Nairn, A Kinoshita-Toyoda, H Toyoda, J Xie, K Harris, S Dalton, M Kulik, JM Pierce, T Toida, KW Moremen, RJ Linhardt |
Journal of Proteome Research | 2007 |
|
Cell surface proteoglycan expression during maturation of human monocytes-derived dendritic cells and macrophages
Y Wegrowski, AL Milard, G Kotlarz, E Toulmonde, FX Maquart, J Bernard |
Clinical & Experimental Immunology | 2006 |
|
Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer
J Li, J Kleeff, I Abiatari, H Kayed, NA Giese, K Felix, T Giese, MW Büchler, H Friess |
Molecular Cancer | 2005 |
|
Radiation leukemia virus common integration at the Kis2 locus: simultaneous overexpression of a novel noncoding RNA and of the proximal Phf6 gene
S Landais, R Quantin, E Rassart |
Journal of virology | 2005 |
|
Hepatocyte growth factor-mediated renal epithelial branching morphogenesis is regulated by glypican-4 expression
A Karihaloo, S Kale, ND Rosenblum, LG Cantley |
Molecular and cellular biology | 2004 |
|
Glypican-3 and Alphafetoprotein as Diagnostic Tests for Hepatocellular Carcinoma
J Filmus, M Capurro |
Molecular Diagnosis | 2004 |
|
Comparative analysis of gene-expression patterns in human and African great ape cultured fibroblasts
MW Karaman, ML Houck, LG Chemnick, S Nagpal, D Chawannakul, D Sudano, BL Pike, VV Ho, OA Ryder, JG Hacia |
Genome research | 2003 |
|
GPC5 is a possible target for the 13q31-q32 amplification detected in lymphoma cell lines
W Yu, J Inoue, I Imoto, Y Matsuo, A Karpas, J Inazawa |
Journal of Human Genetics | 2003 |
|
Glypican‐3 is overexpressed in human hepatocellular carcinoma
Sung YK, Hwang SY, Park MK, Farooq M, Han IS, Bae HI, Kim J, Kim M |
Cancer Science | 2003 |
|
Syndecan-4: Dispensable or indispensable?
SA Wilcox-Adelman, F Denhez, T Iwabuchi, S Saoncella, E Calautti, PF Goetinck |
Glycoconjugate Journal | 2002 |
|
A starting place for the road to function
JE Silbert, G Sugumaran |
Glycoconjugate Journal | 2002 |
|
The contribution of in vivo manipulation of gene expression to the understanding of the function of glypicans
J Filmus |
Glycoconjugate Journal | 2002 |
|
Molecular diversity of heparan sulfate
Jeffery D. Esko, Ulf Lindahl |
Journal of Clinical Investigation | 2001 |
|
Heparan Sulfate: Lessons learned from knockout mice
Erik Forsberg, Lena Kjellen |
Journal of Clinical Investigation | 2001 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)